Back to
Nuveen Asset Management, LLC
SMMT
Showing 2 of 12 quarters
Position history for
Nuveen Asset Management, LLC's holdings in Summit Therapeutics Inc.
As of its last 13F, for Q4 2024, Nuveen Asset Management held 234,426 shares of SMMT (Summit Therapeutics), worth $4.2M. It reduced the position by 35,329 shares (-13.1%) from Q3 2024. Nuveen Asset Management held SMMT from Q2 2023 to Q4 2024, across 7 quarterly 13F filings.
Current Value
$4.2M
Current Shares
234,426
Total Value Change
-$1.7M
Total Shares Change
-35,329
Quarter-by-Quarter History